Insider Transactions in Q1 2023 at Centessa Pharmaceuticals PLC (CNTA)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
Gregory M Weinhoff Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,292
-2.76%
|
$24,876
$3.9 P/Share
|
|
Mar 31
2023
|
David M Chao Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,969
-2.37%
|
$20,907
$3.9 P/Share
|
|
Mar 31
2023
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Payment of exercise price or tax liability
|
Direct |
4,319
-2.68%
|
$12,957
$3.9 P/Share
|
|
Mar 31
2023
|
David J Grainger Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,825
-0.49%
|
$14,475
$3.9 P/Share
|
|
Mar 31
2023
|
Antoine Yver EVP & Chairman of Development |
SELL
Payment of exercise price or tax liability
|
Direct |
3,615
-0.45%
|
$10,845
$3.9 P/Share
|
|
Mar 31
2023
|
Iqbal J Hussain General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
7,080
-3.3%
|
$21,240
$3.9 P/Share
|
|
Mar 31
2023
|
Saurabh Saha Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
22,013
-2.4%
|
$66,039
$3.9 P/Share
|
|
Mar 31
2023
|
Thomas Templeman Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,103
-2.13%
|
$12,309
$3.9 P/Share
|
|
Mar 01
2023
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
7,000
-0.86%
|
$21,000
$3.42 P/Share
|
|
Feb 01
2023
|
Gregory M Weinhoff Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
77,200
+20.43%
|
-
|
|
Feb 01
2023
|
Saurabh Saha Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
211,400
+18.73%
|
-
|
|
Feb 01
2023
|
David J Grainger Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
77,200
+7.29%
|
-
|
|
Feb 01
2023
|
Iqbal J Hussain General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
67,100
+23.81%
|
-
|
|
Feb 01
2023
|
Thomas Templeman Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,400
+23.9%
|
-
|
|
Feb 01
2023
|
David M Chao Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
77,200
+20.82%
|
-
|
|
Feb 01
2023
|
Tia L Bush Chief Technology & Quality Ofc |
BUY
Grant, award, or other acquisition
|
Direct |
30,200
+15.76%
|
-
|
|
Feb 01
2023
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
7,700
-0.94%
|
$23,100
$3.79 P/Share
|
|
Feb 01
2023
|
Antoine Yver EVP & Chairman of Development |
BUY
Grant, award, or other acquisition
|
Direct |
77,200
+8.59%
|
-
|
|
Feb 01
2023
|
Karen M. Anderson Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,700
+50.0%
|
-
|
|
Jan 04
2023
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
6,970
-0.92%
|
$20,910
$3.18 P/Share
|